Virpax Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -3,458 | -3,302 | -4,561 |
EBIT | -3,477 | -6,604 | -5,479 |
Net Income | -3,450 | -3,220 | -4,561 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -1,643 | -7,729 | -3,011 |
Cash | 1,870 | 1,866 | 9,141 |
Basic Shares | 1,977 | 1,171 | 1,171 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -2,249 | -21,650 | -11,963 | -4,191 |
EBIT | -15,189 | -39,995 | -23,988 | -8,387 |
Net Income | -15,189 | -21,456 | -12,148 | -4,487 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -9,853 | -17,846 | -14,542 | -1,384 |
Cash | 9,141 | 18,995 | 36,841 | 54 |
Basic Shares | 1,171 | 1,171 | 1,171 | 494 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.43 |
2024-06-30 | -$1.75 |
2024-03-31 | -$2.74 |
2023-12-31 | -$3.90 |
